Gastroenterology

A large safety analysis of infliximab and adalimumab in pediatric inflammatory bowel disease highlights the need for continued postmarketing monitoring, with new concerns emerging for long-term infliximab use.

A Vietnamese retrospective study challenges the push for endoscopy within 12 hours in patients with esophageal variceal bleeding.

A new study demonstrates that fecal calprotectin levels, measured using fluorescent immunochromatography assay (FICA), strongly correlate with disease activity in ulcerative colitis, offering non-invasive thresholds to better guide patient care.

New research suggests that PRO-C16, a blood-based marker of type XVI collagen formation, may help detect intestinal fibrosis in patients with Crohn’s disease.

A large Iranian study has found no significant association between gastroesophageal reflux disease (GERD) and higher tooth decay rates.

New research reveals that a high-fat diet can boost levels of the gut bacterium Bacteroides thetaiotaomicron, which in turn produces palmitic acid—a fatty acid that enhances blood clotting and cardiovascular risk.

A study of AI-guided infection prevention in hospitals found no drop in C. difficile rates but did see reduced use of risky antibiotics, especially in high-risk patients.

New data from China shows vedolizumab delivers comparable long-term outcomes and safety in elderly and younger patients with moderate-to-severe ulcerative colitis.